loading
前日終値:
$14.07
開ける:
$14.11
24時間の取引高:
1.13M
Relative Volume:
1.00
時価総額:
$11.82B
収益:
$3.85B
当期純損益:
$667.93M
株価収益率:
21.55
EPS:
0.657
ネットキャッシュフロー:
$142.30M
1週間 パフォーマンス:
-0.42%
1か月 パフォーマンス:
-0.21%
6か月 パフォーマンス:
+6.95%
1年 パフォーマンス:
-11.02%
1日の値動き範囲:
Value
$14.03
$14.20
1週間の範囲:
Value
$13.84
$14.22
52週間の値動き範囲:
Value
$12.26
$16.17

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
名前
Dr Reddys Laboratories Ltd Adr
Name
セクター
Healthcare (1145)
Name
電話
-
Name
住所
-
Name
職員
27,811
Name
Twitter
@drreddys
Name
次回の収益日
2025-07-23
Name
最新のSEC提出書
Name
RDY's Discussions on Twitter

RDY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.16 11.71B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.42 64.92B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.60 45.60B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
8.95 39.54B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.01 23.00B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
453.07 20.06B 2.99B 1.21B 1.13B 25.06

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-05 アップグレード HSBC Securities Hold → Buy
2024-12-19 ダウングレード Nomura Buy → Neutral
2024-01-11 ダウングレード Jefferies Buy → Underperform
2023-08-29 ダウングレード HSBC Securities Buy → Hold
2023-05-18 ダウングレード Bernstein Outperform → Mkt Perform
2023-03-17 アップグレード BofA Securities Neutral → Buy
2023-01-30 開始されました JP Morgan Underweight
2022-11-14 ダウングレード Credit Suisse Neutral → Underperform
2022-01-03 再開されました BofA Securities Neutral
2021-07-27 ダウングレード Credit Suisse Outperform → Neutral
2021-02-02 アップグレード Barclays Equal Weight → Overweight
2020-09-18 アップグレード BofA Securities Neutral → Buy
2020-09-18 アップグレード Investec Sell → Hold
2020-01-28 ダウングレード CLSA Buy → Outperform
2020-01-27 ダウングレード CLSA Buy → Outperform
2020-01-09 アップグレード Citigroup Sell → Buy
2019-11-04 ダウングレード BofA/Merrill Buy → Neutral
2019-09-04 アップグレード Credit Suisse Underperform → Outperform
2019-07-01 アップグレード Macquarie Neutral → Outperform
2019-06-20 開始されました Deutsche Bank Hold
2019-06-11 開始されました Barclays Equal Weight
2019-05-20 ダウングレード Morgan Stanley Overweight → Equal-Weight
2019-02-19 アップグレード CLSA Outperform → Buy
2019-01-17 ダウングレード Citigroup Neutral → Sell
2017-09-21 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-08-31 アップグレード CLSA Underperform → Outperform
2017-07-28 ダウングレード CLSA Underperform → Sell
2016-07-27 ダウングレード HSBC Securities Hold → Reduce
2016-07-27 ダウングレード Jefferies Hold → Underperform
2016-02-10 アップグレード Credit Agricole Underperform → Buy
2015-11-10 ダウングレード Citigroup Buy → Neutral
すべてを表示

Dr Reddys Laboratories Ltd Adr (RDY) 最新ニュース

pulisher
Oct 03, 2025

Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040 - GlobeNewswire Inc.

Oct 03, 2025
pulisher
Oct 02, 2025

Asian ADRs Rise As Regional Firms Show Mixed Performance - Finimize

Oct 02, 2025
pulisher
Sep 30, 2025

LLY Stock Quote Price and Forecast - CNN

Sep 30, 2025
pulisher
Sep 26, 2025

Dr Reddys Share Price Update: Company Reports Negative Monthly Returns - Meyka

Sep 26, 2025
pulisher
Sep 24, 2025

GDR, ADR & IDR Companies Stock Prices | IIFL Capital - India Infoline

Sep 24, 2025
pulisher
Sep 24, 2025

NVO Stock Quote Price and Forecast - CNN

Sep 24, 2025
pulisher
Sep 22, 2025

Asian ADRs In The US Start The Week On A High Note - Finimize

Sep 22, 2025
pulisher
Sep 20, 2025

Bizarre Stock Volatility? How Is H1B News Affecting Infosys & Wipro Share Prices On Saturday? - Free Press Journal

Sep 20, 2025
pulisher
Sep 17, 2025

Asian ADR Index Edges Up As LG Display Leads - Finimize

Sep 17, 2025
pulisher
Sep 16, 2025

Dr. Reddy’s Laboratories Allots Equity Shares Under Employee Stock Option Scheme - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Dr Reddy's shares fall as USFDA flags Hyderabad plant with 5 observations - Business Standard

Sep 15, 2025
pulisher
Sep 11, 2025

Asian ADRs Gain As Investors Show Renewed Interest - Finimize

Sep 11, 2025
pulisher
Sep 10, 2025

Asian Equities In The US Logged Broad Gains This Session - Finimize

Sep 10, 2025
pulisher
Sep 03, 2025

Mixed Performance For Asian Stocks Traded In The US - Finimize

Sep 03, 2025
pulisher
Aug 29, 2025

Dr. Reddy’s Laboratories Allots Equity Shares to Employees - TipRanks

Aug 29, 2025
pulisher
Aug 26, 2025

Invesco Ltd. Has $8.12 Million Stake in ATRenew Inc. Sponsored ADR $RERE - Defense World

Aug 26, 2025
pulisher
Aug 25, 2025

Validea's Top Health Care Stocks Based On Peter Lynch8/25/2025 - Nasdaq

Aug 25, 2025
pulisher
Aug 25, 2025

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Barchart.com

Aug 25, 2025
pulisher
Aug 21, 2025

National Bank of Canada FI Boosts Stock Position in Dr. Reddy's Laboratories Ltd $RDY - MarketBeat

Aug 21, 2025
pulisher
Aug 20, 2025

Asian ADRs Trade Lower As S&P Asia 50 Index Drops - Finimize

Aug 20, 2025
pulisher
Aug 18, 2025

Asian Tech Names Lift US-Traded Stocks To A Small Gain - Finimize

Aug 18, 2025
pulisher
Aug 08, 2025

Dr. Reddy’s Subsidiary Imperial Dissolved Following NCLT Approval - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

(PDF) ADRs and underlying stock returns: empirical evidence from India - researchgate.net

Aug 07, 2025
pulisher
Aug 06, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 50% Tariff On India - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Asian Stocks In The US See Mixed Moves Across Sectors - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Trump hikes tariffs on India by additional 25% citing Russian oil trade; iShares India ETF, ADRs react - Moneycontrol

Aug 06, 2025
pulisher
Aug 02, 2025

Asian ADRs Fall As Winners And Losers Stand Out - Finimize

Aug 02, 2025
pulisher
Aug 01, 2025

Dr Reddys Laboratories Faces Continued Stock Decline Amid Broader Market Challenges - Markets Mojo

Aug 01, 2025
pulisher
Jul 31, 2025

Asian ADRs Falter On US Markets As Fintechs Slide - Finimize

Jul 31, 2025
pulisher
Jul 31, 2025

Trump’s Tariffs on India highlights: Sensex falls 800 points, Trump launches fresh attack on India for Russia ties - Mint

Jul 31, 2025
pulisher
Jul 30, 2025

Trump Tariff Impact: Infosys, Wipro, HDFC Bank, Other ADR Shares Drop After US Levies 25% Tariff On India - MSN

Jul 30, 2025

Dr Reddys Laboratories Ltd Adr (RDY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$10.19
price up icon 0.79%
$52.54
price down icon 9.21%
$20.64
price up icon 0.83%
$137.03
price up icon 0.21%
$453.07
price up icon 2.17%
大文字化:     |  ボリューム (24 時間):